Rezorstobart is a humanized monoclonal antibody designed to target KLRB1 (CD161), a receptor expressed on NK cells and T cell subsets. It is a valuable tool for immunological research, enabling the investigation of KLRB1 function in both in vitro cellular assays and in vivo disease models.
Konzentration:
14.728 mg/mL
Molekulargewicht:
~150 kDa
Reinheit:
97.45% (May vary between batches)
CAS Nummer:
[2762201-86-3]
Target-Kategorie:
Immunology/Inflammation related
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten